HomeHealthDistant affected person monitoring startup Alio scores $18M | NEWSRUX

Distant affected person monitoring startup Alio scores $18M | NEWSRUX

Distant affected person monitoring firm Alio scooped up $18 million within the first shut of a Sequence C funding spherical.

The increase was led by the Widjaja Household Funding Workplace with participation from present buyers, together with Chase Subject, LLC and Thomas Krebs, former treasurer of medical system firm Penumbra.

Alio mentioned the Sequence C brings its complete quantity the corporate has raised to greater than $50 million.  The startup final raised $20 million in Sequence B funds in 2021. 


Alio presents a distant monitoring system for power situations, presently centered on sufferers present process dialysis.

Earlier this yr, the corporate introduced the system had obtained FDA 510(okay) clearance to gather physiological information — like pores and skin temperature, auscultation, or inner physique sounds, and coronary heart fee — within the house. 

In keeping with the 510(okay) abstract, the system consists of the SmartPatch wearable sensor, its Bedside Hub which collects and uploads patch information, the Alio Medical Cloud that shops that info, and a clinician-facing portal. 

Alio mentioned it has accomplished one other submission to the FDA to obtain clearance to watch hemoglobin, hematocrit and potassium. It expects a response within the first half of subsequent yr, and the corporate plans to commercially launch the platform if it receives the company’s inexperienced gentle. 

Funds from the Sequence C spherical will go in the direction of increasing Alio’s distant affected person monitoring tech and scaling operations.

“We made large progress over this previous yr — we achieved a significant regulatory milestone with our preliminary FDA clearance for our platform, accomplished our FDA submission to incorporate potassium monitoring and fashioned a variety of strategic partnerships, laying the groundwork for commercialization. With this robust basis established, we’ve reached a important level in our journey,” Alio cofounder and CEO David Kuraguntla mentioned in an announcement. 


Distant affected person monitoring use grew through the COVID-19 pandemic, in response to an evaluation of conventional Medicare claims revealed in JAMA Inside Drugs earlier this yr. Although nonetheless small, the examine’s authors word extra analysis might be achieved to find out the place RPM might be most helpful, like stopping hospital readmissions.

There are a variety of firms growing RPM know-how. GE Healthcare just lately partnered with AMC Well being to supply distant affected person monitoring know-how to sufferers after they have been discharged from the hospital.

One other firm within the RPM area is Biofourmis, which introduced a $300 million Sequence D in April that boosted its valuation to $1.3 billion. In August, the corporate mentioned it had added one other $20 million to its Sequence D increase. 

#Distant #affected person #monitoring #startup #Alio #scores #18M


  • Donate withBitcoin
  • Donate withDogecoin
  • Donate withLitecoin
  • Donate withTether
  • Donate withBinance coin
  • Donate withTron
  • Donate withBitcoin cash
  • Donate withDash
  • Please Add coin wallet address in plugin settings panel


New updates